Charles River Laboratories (CRL)致力于为全球制药企业、生物技术公司、政府机构及科研院所提供必要产品及服务，加速其研究和药物开发进程。CRL的专业化团队始终致力于为客户提供所需的全方位服务，涵盖新疗法的开发、早期发展以及安全生产等多个方面。如希望更详细了解 CRL 的产品和服务范围，请访问 www.criver.com 。

CRL在全球拥有150余设施和站点，我们的战略定位是协调全球资源，运用多学科视角解决您产品的独特挑战。我们在开发的每个阶段都注重及时性和准确性，这意味着您可以获得可靠的、可重复的结果 — every step of the way 。

•成立时间：1947年

•总部：马萨诸塞州威尔明顿

•员工人数：全球21,000多名

•收入：2023财年41.3亿美元

•所有权：纽约证券交易所 NYSE: CRL

•客户：全球制药，生物技术，农用化学品，政府和学术组织

•服务领域：基础研究，新药发现，安全性和有效性评价，临床支持和制造

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com